StocksFin Logo
Co-Diagnostics, Inc. country of incorporation
|
|
Mr. Dwight Egan
|
101 employees
NASDAQ | Healthcare | Medical Devices
Omeros Corporation country of incorporation
|
|
Dr. Gregory Demopulos
|
213 employees
NASDAQ | Healthcare | Biotechnology
Q322 reported Nov 10, 2022 Reporting Period
$5.09M -83.1% vs. Q321 Revenues Q322
84.93% -4.6% vs. Q321 Gross Profit Margin
-109.73% ! -387.8% vs. Q321 Net Profit Margin
9.44M -18% vs. Q321 Free Cash Flow Q322
$-0.18 ! -145% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Nov 9, 2022 Reporting Period
$0 -100% vs. Q321 Revenues Q322
0% -100% vs. Q321 Gross Profit Margin
0% 100% vs. Q321 Net Profit Margin
-61.2M ! -158.7% vs. Q321 Free Cash Flow Q322
$0.6 266.7% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
15.83
5.94
Current Ratio
16.95
7.3
Cash Ratio
13.56
3.68
Price to Book
0.75
-4.27
Price to Sales
19.74
0
Price to Earnings
-4.5
1.32